Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2004-09-28
2010-06-22
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07741034
ABSTRACT:
Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.
REFERENCES:
patent: 5670314 (1997-09-01), Chistman et al.
patent: 6174681 (2001-01-01), Halling et al.
patent: 6344315 (2002-02-01), Gray et al.
patent: 6376188 (2002-04-01), Halling et al.
patent: 6475720 (2002-11-01), Gray et al.
patent: 6576420 (2003-06-01), Carson et al.
patent: 6689561 (2004-02-01), Carson et al.
patent: 6780592 (2004-08-01), Sidransky
patent: 6797471 (2004-09-01), Katz et al.
patent: 6846650 (2005-01-01), Recipon et al.
patent: 2002/0160409 (2002-10-01), Halling et al.
patent: 2003/0087248 (2003-05-01), Morrison et al.
patent: 2003/0119080 (2003-06-01), Mangano
patent: 2003/0138928 (2003-07-01), Carson et al.
patent: 2004/0126398 (2004-07-01), Jager et al.
patent: 2004/0171567 (2004-09-01), Sidransky et al.
patent: WO 01/38389 (2001-05-01), None
patent: WO 02/12563 (2002-02-01), None
Shriver et al. (Mutation Research Genomics, vol. 406, No. 1, pp. 9-23, Nov. 1998).
Petersen, Oncogene, vol. 17, pp. 449-454, 1998.
Nastiuk et al (Prostates, vol. 40, No. 3, pp. 172-177, 1999).
Hosoya et al. (Lung Cancer, vol. 25, pp. 87-93, 1999).
Okada (Cancer Research, vol. 54, pp. 3979-3982, Aug. 1994).
Gasparotto et al. (Int. J. Cancer, Vo. 84, pp. 432-436, Nov. 10, 1999).
Kim et al. (Oncogene, vol. 16, pp. 89-93, 1998).
Alberola et al., “Prognostic significance of flow cytometry and EGFR in resectable non-small cell lung cancer (NSCLC): results of a prospective study,”Proc. Annu. Mt. Am. Soc. Clin. Oncol.,14: 359, Abstract A1094, 1995.
Auerbach et al., “Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer,”N. Engl J. Med.,265: 253-267, 1961.
Ayabe et al., “DNA stemline heterogencity of non-small cell lung carcinomas and differences in DNA polidy between carcinomas and metastactic nodes,”Lung Cancer,11(3-4): 201-208, 1994.
Barinaga, “An intriguing new lead on Huntington's Disease,”Science,271: 1233-1234, 1996.
Bepler et al., “Association of chromosome 11 locus D11S12 with histology, stage, and metastases lung cancer,”Cancer Detection and Prevention,22(1):14-29, 1998.
Bockmuhl et al., “Deletion of chromosome 10q—a marker for metastasis of head-neck carcinomas?”Laryngorhinootologie,79(2):81-85, 2000, article in German, English abstract included.
Brugal et al., “Image analysis of microscopic preparations,”Method. Achiev. Exp. Pathol.,11: 1-33, 1984.
Carney et al., “Influence of histologic subtype of small cell carcinoma of the lung on clinical presentation, response to therapy and survival,”JNCI,65:1225-1230, 1980.
Carriaga et al., “The histologic grading of cancer,”Cancer,75:406-421, 1995.
Cheon et al., “Flow cytometric analysis of DNA ploidy in primary non-small cell carcinoma of the lung in Korea,”Yonsei Med. J.,34(4): 365-370, 1993.
Czerniak et al., “Genetic model of human urinary bladder carcinogenesis,”Genes, Chromosomes, and Cancer,27:392-402, 2000.
Czerniak et al., “Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer,”Oncogene,18:1185-1196, 1999.
Dalquen et al., “DNA aneuploidy, s-phase fraction, nuclear p53 positivity, and survival in non-small-cell lung carcinoma,”Virchows Archiv.,431(3): 173-179, 1997.
Daly et al., “A homozygous deletion on chromosomes 3 in small cell lung cancer cell line correlates with a region of tumor suppressor activity,”Oncogene,8(7):1721-1729, 1993.
Dong et al., “KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2,”Science,268:884-886, 1995.
Feder et al., “Clinical relevance of chromosome abnormalities in non-small cell lung cancer,”Cancer Genet. Cytogenet.,102: 25-31, 1998.
Feinstein et al., “Observer variability in the histopathologic diagnosis of lung cancer,”Am Rev Repir Dis,101:671-684, 1970.
Feinstein et al., “The diverse effects of histopathology on manifestations and outcome of lung cancer,”Chest,66(3):225-229, 1974.
Field et al., “Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer,”Can Res.,59:2690-2695, 1999.
Fontanini et al., “The expression of proliferating cell nuclear antigen in paraffin sections of peripheral, Node-negative non-small cell lung cancer,”Cancer,70(6): 1520-1527, 1992.
Hirano et al., “Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression,”American J. Path.,144(2): 296-302, 1994.
Hirsch et al., “Intracranial metastases in small cell carcinoma of the lung,”Cancer,51:529-533, 1983.
Hirsch et al., “The prognostic significance of histopathologic subtyping of small cell carcinoma of the lung according to the classification of the world health orgainization,”Cancer,52:2144-2150, 1983.
Hung et al., “Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma,”JAMA,273(7):558-563, 1995.
Ichinose et al., “Postoperative adjuvant chemotherapy in non-small cell lung cancer: prognostic value of DNA ploidy and post-recurrent survival,”J. Surgical Oncology,46(1): 15-20, 1991.
Ihde, “Non-small cell lung cancer. Biology, diagnosis and staging,”Curr. Prob. Cancer,15:63-104 1991.
Ji et al., “Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector in tumor suppressor activities in vitro and in vivo,”Cancer Research,62:2715-2720, 2002.
Kim et al., “DNA ploidy and proliferative activity in bc1-2 expressed non-small cell lung cancer,”Korean J. Intern. Med,11(2):101-107, 1996.
Licciardello et al., “Multiple primary cancer in patients with cancer of the head and neck: second cancer in the head and neck, esophagus and lung,”Int. J. Radiat. Oncol. Bio. Phys.,17: 467-476, 1989.
Liewald et al., “Flow cytometric analysis of non-small-cell bronchial carcinoma and its prognostic significance,”Chirurg,63(3): 205-210, 1992, Article in German, English abstract included.
Lifton, “Molecular genetics of human blood pressure variation,”Science,272: 676-680, 1996.
Macchiarini et al., “Risk of cancer recurrence in completely resected T1N0M0 non-small cell lung cancer (NSCLC),”Proc Annu Mt. Am. Soc. Clin. Oncol.11:297, abstract # 995, 1992.
Miki et al., “A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1,”Science,266: 66-71, 1994.
Mitsudomi et al., “Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication,”Clin. Cancer Res.,2(7): 1185-1189, 1996.
Miura et al., “Chromosome alterations in 21 non-small cell lung carcinomas,”Genes Chromosomes Cancer,2(4):328-338, 1990.
Miyamoto et al., “Prognostic value of nuclear DNA content and expression of the RAS oncogene product in lung cancer,”Cancer Research,51: 6346-6350, 1991.
Morahan et al., “Markers on distal chromosome 2q linked to insulin-dependent diabetes melliuts,”Science,272: 1811-1813, 1996.
Morkve et al., “Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas,”Anticancer Research,13(3): 571-578, 1993.
Muguerza et al., “Prognostic value
Jiang Feng
Katz Ruth
Board of Regents , The University of Texas System
Fulbright & Jaworski L.L.P.
Goldberg Jeanine A
LandOfFree
Detection and diagnosis of smoking related cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection and diagnosis of smoking related cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection and diagnosis of smoking related cancers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4162684